• Molecular NameTrabectedin
  • SynonymEcteinascidin; Ecteinascidin 743; ET-743; ET743; NSC 684766
  • Weight761.849
  • Drugbank_IDDB05109
  • ACS_NO114899-77-3
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.8
  • pkaN/A
  • LogD (pH=7, predicted)0.8
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.46
  • LogSw (predicted, AB/LogsW2.0)36.09
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors4
  • No.of HBond Acceptors14
  • No.of Rotatable Bonds4
  • TPSA194.02
  • StatusFDA approved
  • AdministrationIntravenous
  • PharmacologyAn anti-tumor drug.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding96.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic (mostly CYP3A4-mediated)
  • Half life180 h
  • ExcretionMostly fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A